Head of Department, Oncology

Dr. Willumsen joined Nordic Bioscience in 2012 and assumed the position as head of department in Oncology in 2016. His research group focuses on development of blood-based biomarkers to quantify the tumor matrix in serum from patients with cancers to understand pharmacodynamics/efficacy/resistance mechanisms of treatments. Research activities in the group span from biomarker discovery to preclinical and clinical validation of findings.

H-index: 16. i10-index: 25. Citations: 686

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.

We use cookies on our site to enable essential services and functionalities, and collect data in regards to visitor information to provide the best possible experience. By using our website, you agree to our Privacy Policy and our cookies usage. Cookie Policy Privacy Statement